The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. - Wikidata - awgldk - TriplyDB

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.

http://www.wikidata.org/entity/Q43983471

about

Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions mTOR inhibitors for management of encapsulating peritoneal sclerosis: a review of literatures.Histological and clinical findings in patients with post-transplantation and classical encapsulating peritoneal sclerosis: a European multicenter study.Can EPS development be avoided with early interventions? The potential role of tamoxifen--a single-center study Fibrin-Induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells as a mechanism of peritoneal fibrosis: effects of pentoxifylline Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.Encapsulating peritoneal sclerosis-a rare but devastating peritoneal disease.Post-transplantation encapsulating peritoneal sclerosis without inflammation or radiological abnormalities.Encapsulating Peritoneal Sclerosis - A rare and serious complication of peritoneal dialysis: Case series.Methylglyoxal Induced Basophilic Spindle Cells with Podoplanin at the Surface of Peritoneum in Rat Peritoneal Dialysis Model Encapsulating peritoneal sclerosis as a late complication of peritoneal dialysis.Case report: acute bowel obstruction with an isolated transition point in peritoneal dialysis patients; a presentation of encapsulating peritoneal sclerosis?C-reactive protein levels in combination with abdominal CT scans is a useful tool to predict the macroscopic appearance in late-stage EPS patients prior to surgery.Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients.Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis.Incidence and outcome of encapsulating peritoneal sclerosis Encapsulating peritoneal sclerosis: case series from a university center.Towards standardized reporting in studies of encapsulating peritoneal sclerosis.Persistent sterile peritoneal inflammation after catheter removal for refractory bacterial peritonitis predicts full-blown encapsulating peritoneal sclerosis Nutrition changes in conservatively treated patients with encapsulating peritoneal sclerosis.Encapsulating peritoneal sclerosis: a single-center experience and review of the literature.Encapsulating peritoneal sclerosis in children.Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study.Designing Epidemiology Studies to Determine the Incidence and Prevalence of Encapsulating Peritoneal Sclerosis (EPS).Can radiological assessment of abdominal computerized scans diagnose encapsulating peritoneal sclerosis in long-term peritoneal dialysis patients?m-TOR inhibitors may be useful in the treatment of encapsulating peritoneal sclerosis (EPS).Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients.Successful outcome with early renal transplantation following treatment of encapsulating peritoneal sclerosis.Encapsulating peritoneal sclerosis in an Italian center: thirty year experience.Late presentation of encapsulating peritoneal sclerosis following renal transplantation and the potential under-reporting of the incidence and prevalence of encapsulating peritoneal sclerosis.The Role of NGAL in Peritoneal Dialysis Effluent in Early Diagnosis of Peritonitis: Case-Control Study in Peritoneal Dialysis Patients.Combined surgical and immunosupressive therapy for encapsulating peritoneal sclerosis.Fibrosing pericarditis in a patient with encapsulating peritoneal sclerosis.Is there an end in sight for encapsulating peritoneal sclerosis?Encapsulating peritoneal sclerosis: surgery, sustained drug therapy and treatment of recurrence at 1 year.Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis-experience of a referral centre in Germany.Combined intestine and kidney transplantation in a patient with encapsulating peritoneal sclerosis: case report.Lower mortality and inflammation from post-transplantation encapsulating peritoneal sclerosis compared to the classical form.Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group.Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children.

P2860

Q28082263-3F60DC9A-F1EB-4416-90B6-548AC2EC2661 Q30248955-FF1041DE-21D7-4E7F-B850-ACBFF91B8F9A Q34110645-903AC47E-6939-41D5-8034-7D2339D45B94 Q34182891-651DC0B3-A1EC-4788-8066-7FA1EF626DB1 Q34427394-F497D816-5C17-4821-B116-A66E5DD006FA Q34700117-C32F8694-AE9A-4907-B9D2-4B7CAF8024DD Q34816520-8BB864E5-F0B3-4297-B462-115371CD21E2 Q34997813-84C3A5B1-875F-4EC4-9C63-E1A5424640B7 Q35340533-99903563-A131-44A8-9A99-431AD7E74CEA Q35612422-56DA6A17-F7D3-430F-9A92-65BE19B26C4E Q35801666-A77416B0-7D5F-4679-8634-4F1015D3306D Q35884284-20A9E077-37E2-4695-BD34-F27B43FF7972 Q35965920-E8A5DA36-FD6E-4765-9AA8-BA08309757F6 Q36000601-24A1E804-0B10-468B-866A-ABF87F0547A0 Q36348476-AB6DA7FC-8E31-4909-B042-4DA733CBFDB4 Q37119072-6A19A829-CBC2-4417-A206-440CDED88BC9 Q37138761-E06BF8CD-C011-4DA9-915B-9948C1DEBE4C Q37232268-C5D5B140-3709-4222-876E-A3F8DEA52D28 Q37232281-27E1BC49-E5D7-483E-A000-DBB7A3A26DFB Q37232291-4D0DD90F-5260-4BA2-88BA-B6DF3B09F53E Q37798183-C67AF05D-7FB3-49AD-AEC4-59F936C93B4E Q38164559-8E60592E-5E9B-45F9-8F67-A57BBC2721E8 Q38444094-726B22C4-8965-44E8-95FA-34EDE94788A9 Q38679341-DB2C099A-271D-4B2D-8124-9BDB6F43CA8C Q38924674-A2CF4351-ACAF-48EB-B651-73B64D1E61C4 Q39251820-3D42A258-5E1F-4E8E-8B80-28ED688C8E73 Q39255808-96DE9B82-B890-446F-AAC1-2520FB1DDCA1 Q40338434-DF8D7E1D-698E-42E5-960F-D37EB89BE83D Q40370185-FC1386A1-8C06-4AFB-BE8F-BAADF523ED39 Q40847775-AC9ADB20-7AF9-46EF-9540-B516B4AADC16 Q41109848-96BD9B03-5041-4F26-9015-4CB924535862 Q42360709-ED41D4A6-6BBC-4D05-AD16-6709446A0F75 Q42415654-8860C347-210E-4908-93EF-1F4D876ACA63 Q42877837-FF817F0C-9F84-4679-A646-B67597E5C79F Q43162380-0DD154FD-3B0D-4E35-AC4D-0C48C676AFB9 Q43608010-5695B54B-5515-43C8-A1E1-D355ED78D0A2 Q43873901-01DACFD8-0D39-40B0-A79A-8CBB656F46E7 Q45416710-5F733DA4-5191-4AB6-89BD-656D46198924 Q46866824-66EC361E-1553-4CFC-ACCC-90E0AAF817E7 Q47128504-4390D1F1-F98D-4122-9983-3FE6F6CC748E

P2860

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.

http://www.wikidata.org/entity/Q43983471

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.

@en

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.

@nl

type

label

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.

@en

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.

@nl

prefLabel

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.

@en

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.

@nl

P1433

Q43983471-51C8E16C-5028-4459-ACFE-AD04F91F5996

P1476

Q43983471-4085D238-E340-4E2F-9322-E4373558FAB0

P2093

Q43983471-096AD934-E8B6-48C3-9EE2-1CDC309D022D

Q43983471-26A175C2-E8EA-49DC-B0DF-7F89DECDABC2

Q43983471-3ABC80E9-6CB3-4380-A086-A5F081EABC8F

Q43983471-70F7C101-EE3E-4DEE-BF80-47359EB9BA4E

Q43983471-ACD262A9-C071-4A54-8702-078851E7DE5F

Q43983471-B27FE086-FAC1-46EF-96F2-5BFE59AC6EB3

Q43983471-B5190E30-5DBD-4E8E-908F-00AD293C7D50

Q43983471-D6F83E13-FEB6-4F1E-928B-F1B6293E4737

Q43983471-F9358956-FCD8-4B82-891C-9B4DE499D289

Q43983471-FE93D1BF-3B7E-4725-8853-FE9F1D0B56EC

P2860

Q43983471-082BEE54-5F93-4FD1-B693-EBF129F9719A

Q43983471-4CD83D71-E11A-49F7-8D1F-5010FB1C10CC

Q43983471-4CE0574D-A7D9-41F1-95A7-AE93FB9EB8AA

Q43983471-A176640C-C2DA-4ECF-8CA0-CE88E9944191

Q43983471-AFDCE0EC-89F6-4301-BDE2-FBC7A6E0C8C7

Q43983471-B5CC01D1-9694-4559-AE3C-B30A933AF13E

Q43983471-BE9C1A03-FDBB-4390-A263-F3AA29294D1C

P304

Q43983471-7C62D892-C837-4D5B-A2D2-D899B46183FD

P31

Q43983471-46C6A8ED-77A8-42D8-94A3-436F60E500B3

P356

Q43983471-4D8F5C4D-03AF-4049-9663-C30CC3F4C7B1

P407

Q43983471-4438C854-C8CC-4A3D-885B-C652CE9CA405

P433

Q43983471-B429D8A5-7F71-49A6-99A4-72B3D5216152

P478

Q43983471-BD9050DC-0D28-4221-B802-8BD6AFC35A24

P50

Q43983471-025559C5-57B6-42BB-B9D5-1B22D176D18C

P577

Q43983471-099A4460-D16A-4927-9F67-03C51F1E66D1

P5875

Q43983471-C93BCE88-1967-4E3A-AA82-3CA21D43268F

P698

Q43983471-C5456A97-F484-45BA-9D0C-EA14401A1764

P356

P1433

Nephrology Dialysis Transplantation

P1476

The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.

@en

P2093

Andrew Davenport

http://www.w3.org/2001/XMLSchema#string

Barbara Cooper

http://www.w3.org/2001/XMLSchema#string

Edwina A Brown

http://www.w3.org/2001/XMLSchema#string

Gowrie Balasubramaniam

http://www.w3.org/2001/XMLSchema#string

Hugh Cairns

http://www.w3.org/2001/XMLSchema#string

Ken Farrington

http://www.w3.org/2001/XMLSchema#string

Patrick Harnett

http://www.w3.org/2001/XMLSchema#string

Sally Krausze

http://www.w3.org/2001/XMLSchema#string

Simon Steddon

http://www.w3.org/2001/XMLSchema#string

Stanley L S Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure.

Sclerosing encapsulating peritonitis associated with continuous ambulatory peritoneal dialysis: surgical management.

Differential Effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis.

Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group.

Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy.

Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat.

Sclerosing peritonitis: the experience in Australia.

P304

3209-3215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFP008

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24002741

http://www.w3.org/2001/XMLSchema#string

P698

19211652

http://www.w3.org/2001/XMLSchema#string